News - POCTRN
Webinar: Wastewater Surveillance for COVID-19 and Other Infectious Diseases
Webinar: Beyond Epitope Mapping
Webinar: Medtech/Lifesciences Manufacturing in the United States
Webinar: Communicating COVID Safety Practices
Webinar: Immune Control and Evasion of Viral Infection
Webinar: Pathogen Surveillance for Emergent Epidemics
Webinar: The Evolution of SARS-CoV-2 Variants and Effects on Viral Detection Tests
POCTRN Solicitation 2022
Webinar: The Epidemiology of Omicron
Webinar: Overview of Long COVID
WhenToTest.org Develops Tool to Guide Individuals on COVID-19 Testing
Independent Test Assessment Program (ITAP)
Webinar: Lessons Learned from 2020 Provide a Springboard for Increased Telehealth Adoption
COVID-19 Testing Is Here to Stay: The Intersection Between Vaccination and Testing
WhenToTest.org Develops Online Tools for Effective COVID-19 Testing
Webinar: COVID-19 Vaccines: How did we get here and where are we going?
Up to 100K and Mentorship Available for Innovative Neurotechnologies
RADx Tech: A New Paradigm for MedTech Development
RADx Tech II: Fast-Track Program to Advance U.S. COVID-19 Testing Capabilities
Acceleration of Sustainable K-12 School Re-openings for In-person Learning
The RADx Tech Process
Returning to In-Person Instruction for K-12 Schools
RADx Webinar: The Epidemiology of COVID-19
binx health Receives FDA CLIA Waiver for Chlamydia and Gonorrhea Test, Expanding Critical Access to Single-Visit Diagnoses
Emergence of SARS-CoV-2 Variants and Impact on IVD Testing
WhenToTest.org
Future potential of Rapid Acceleration of Diagnostics (RADx Tech) in molecular diagnostics
POCTRN Solicitation 2021
RADx Tech Webinar Series: A Path to In-Person Instruction
NIH-funded COVID-19 home test is first to receive over-the-counter authorization from FDA
RADx Pooling Task Force
Global View of COVID-19: A Pan-African Perspective
RADx Tech Webinar Series: A Year of RADx Tech
University Lab Partners Selected by CIMIT to Partner in their Project to Support the NIH RADx Initiative
NIH RADx Initiative Advances Six New COVID-19 Testing Technologies
RADx Tech Webinar Series: Delivering New COVID-19 Technologies to Close the Testing Gap in the US Market
Overcoming Challenges With the Adoption of Point-of-Care Testing
Webinar: Insights from User Discussions on COVID-19 Testing in Non-Traditional Settings
NIH Continues to Boost National COVID-19 Testing Capacity
The Forsyth Institute Serving as a Critical Resource for COVID-19 Saliva Diagnostic Test Development
Webinar: Covid-19 Testing
Webinar: Returning to Normal Activities
NIH delivering new COVID-19 testing technologies to meet U.S. demand
NIH LIVE QA Session
PathogenDx Receives Federal Grant From the NIH As Part of the RADx Program
RADx Tech COVID19 Webinar Series: Regulatory Affairs on the RADx Frontlines
Rapid Scaling Up of Covid-19 Diagnostic Testing in the United States — The NIH RADx Initiative
3M and MIT Researchers Developing a Rapid Diagnostic Test for COVID-19
RADx Tech COVID19 Webinar Series: As the Coronavirus Pandemic Unfolds...
RADx Tech COVID19 Webinar Series: As the Coronavirus Pandemic Unfolds...
RADx-UP Funding Opportunities and Webinar
Francis Collins Testifies Before Congress, May 7, 2020
Important COVID-19 Survey
NIH Announces $1 Million Prize Competition to Target Global Disease Diagnostics
POCTRN CRAASH 2020
POCTRN Solicitation 2020
GLUE Lecutre Series: Channeling your Inner MacGyver
IEEE EMB HI-POCT Conference
Webinar: Point of Care Tests
GLUE Lecture Series: Tales from the ICU
Webinar: Understanding the FDA - Accelerating the Pathway to Approval for Point-of-Care Technologies
Use of a Rapid Diagnostic for Chlamydia Trachomatis and Neisseria Gonorrhoeae for Women in the Emergency Department Can Improve Clinical Management
Webinar: Ensuring Success of Point of Care Technologies with a Systems Engineering Approach

RADx: Rapid Acceleration of Diagnostics
In response to the COVID-19 pandemic, the Rapid Acceleration of Diagnostics (RADxsm) initiative was formed to accelerate the development, validation, and commercialization of innovative point-of-care and home-based tests, as well as improvements to clinical laboratory tests, that can directly detect SARS-CoV-2, the virus that causes COVID-19.
In the News
NIH RADx initiative expands COVID-19 testing innovation for additional types of rapid tests
The need for new test verification and regulatory support for innovative diagnostics
NIH-funded screening study builds case for frequent COVID-19 antigen testing
RADx partnerships speed new COVID testing
Publication reveals essential ingredients of the groundbreaking NIH RADx national diagnostics effort
RADx Expects COVID-19 Portfolio to Accelerate an Era of At-Home Infectious Disease Testing (Login Required)
COVID-19 Testing: Three Breakthrough Solutions in the RADx Initiative
The National Strategy From the COVID-19 Response and Pandemic Preparedness